An extended APOBEC3A mutation signature in cancer
The APOBEC mutation signature contributes to a significant percentage of human cancers. Here the authors via biochemical and computational analyses shed light on how DNA primary sequence and secondary structure jointly influence A3A substrate optimality.
Guardado en:
Autores principales: | Adam Langenbucher, Danae Bowen, Ramin Sakhtemani, Elodie Bournique, Jillian F. Wise, Lee Zou, Ashok S. Bhagwat, Rémi Buisson, Michael S. Lawrence |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0df7d51a696e4dfaa11c6266dbb37d50 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Quantification of ongoing APOBEC3A activity in tumor cells by monitoring RNA editing at hotspots
por: Pégah Jalili, et al.
Publicado: (2020) -
Genotoxic stress and viral infection induce transient expression of APOBEC3A and pro-inflammatory genes through two distinct pathways
por: Sunwoo Oh, et al.
Publicado: (2021) -
Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance
por: Bin Zhu, et al.
Publicado: (2020) -
APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism
por: Ting-Wen Chen, et al.
Publicado: (2017) -
Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo.
por: Spyridon Stavrou, et al.
Publicado: (2014)